Turanabol Tablets by British Dragon

The structural difference is a single chlorine atom at the C4 position. In Methandrostenolone (Methanabol/Dianabol), this position is unsubstituted — the compound aromatizes via the enzyme aromatase, converting to a methylestradiol derivative that produces estrogenic activity: water retention, potential gynecomastia, and the weight increases characteristic of Dianabol cycles. The C4-chloro substitution in Turinabol creates steric interference that blocks the aromatase enzyme's access to the C4 position, completely preventing the aromatization reaction. No conversion to estrogen occurs at any dose. No estrogen means no estrogen-driven water retention, no estrogen-driven gynecomastia, and no post-cycle weight loss from fluid normalisation. The mass gained on a Turinabol cycle consists entirely of lean tissue — slower to accumulate than Methanabol's rapid wet mass but fully retained after the cycle, making Turinabol's net lean mass outcome over a comparable cycle duration competitive with or superior to Methanabol's, despite producing a lower scale weight increase.

Turinabol's low androgenic rating (approximately 6 relative to testosterone's 100) makes it one of the more female-appropriate anabolic compounds available — lower androgenic than Nandrolone (37), Methandrostenolone (40-60), and substantially lower than testosterone (100) or Trenbolone (500). Female athletes have used it at 10–20 mg/day for lean mass and strength development with lower virilization risk than most comparable compounds. However, "lower risk" does not mean "no risk" — any exogenous androgen can cause virilization in women, and the threshold for irreversible virilization effects (voice deepening, clitoral enlargement) varies significantly between individuals. Female use requires: the lowest effective dose (start at 10 mg/day); immediate and complete discontinuation at any early virilization symptom (increased body hair, voice changes, clitoral sensitivity changes); cycle lengths of 4–6 weeks maximum; and no co-administration with other androgenic compounds. The 10 mg tablet size from Turanabol Tablets is well suited to female dosing, allowing precise 10 mg increments.

Multiple pharmacological and operational factors combined to make Turinabol the optimal selection for a broad multi-sport institutional program. First, zero aromatization: female athletes — who represented a significant proportion of the program's participants — are sensitive to estrogenic side effects and virilization from androgenic compounds. A compound with no estrogenic activity and low androgenicity could be dosed across male and female athletes with a unified protocol structure. Second, lean profile without water: sports with weight categories, aesthetic scoring, or cardiovascular performance requirements needed mass gains without the water weight and cardiovascular burden of estrogenic compounds. Third, the detection window available to 1970s–1980s testing infrastructure was manageable for a compound with Turinabol's metabolic half-life — the program operated on calculated clearance periods before competition testing. Fourth, Jenapharm was a domestic East German manufacturer, providing supply security for a state-controlled program that could not rely on foreign pharmaceutical supply chains.

Sex hormone binding globulin is a blood plasma protein that binds testosterone and other androgens — when bound to SHBG, hormones are pharmacologically inactive. Only the unbound "free" fraction of testosterone produces biological effects at the androgen receptor. Turinabol competes with testosterone for SHBG binding sites — it has a high affinity for SHBG relative to its androgenic receptor activity, meaning it occupies SHBG binding capacity without producing proportional androgenic effect through that binding. The result is a reduction in the proportion of endogenous or exogenous testosterone bound to SHBG, increasing the free (biologically active) testosterone fraction. In a cycle combining Turanabol Tablets with an injectable testosterone compound, the Turinabol-driven SHBG suppression amplifies the effective activity of the testosterone dose by increasing the percentage available for receptor interaction. This pharmacodynamic interaction means that 500 mg/week of Testosterone Enanthate combined with Turinabol 40 mg/day produces more biologically active testosterone at the receptor level than 500 mg/week of Testosterone Enanthate alone — without increasing the total testosterone dose or its aromatization burden.

As a kickstart (typically weeks 1–6 of a long-ester injectable cycle), Turinabol serves a specific function: covering the 3–6 week loading phase during which long-ester injectables (Testosterone Enanthate, Nandrolone Decanoate) accumulate to steady-state plasma levels. During these initial weeks, the injectable compounds are not yet at full anabolic effect — Turinabol's immediate oral activity provides lean mass and strength contribution from cycle day one, preventing the unproductive early-cycle period that long-ester-only protocols involve. The hepatic burden is limited to the kickstart duration (6 weeks), after which Turinabol is discontinued and the injectables carry the cycle forward. Running Turinabol throughout the full cycle (12–14 weeks) extends this lean mass and SHBG-suppression contribution for the entire cycle duration but imposes hepatotoxicity across a period (beyond 8 weeks) where liver enzyme accumulation becomes a genuine concern. For the athlete choosing between the two: the kickstart approach optimises Turinabol's contribution to the most pharmacologically critical phase of the cycle while limiting hepatic exposure; the full-cycle approach provides continuous SHBG suppression and oral anabolic contribution at the cost of extended hepatic burden that requires active monitoring and aggressive liver support throughout.

Most users notice the first effects within the first one to two weeks of dosing.

The side profile depends on the compound class - the Side Effects section on the product page above covers the exact watchpoints for turanabol.

Oral compounds clear within days of the last dose; injectable esters extend detection to weeks or months depending on the ester.

British Dragon Turanabol Tablets is available in this shop with international and domestic shipping.